1.46
price down icon2.67%   -0.04
after-market 시간 외 거래: 1.46
loading
전일 마감가:
$1.50
열려 있는:
$1.51
하루 거래량:
113.34K
Relative Volume:
0.20
시가총액:
$3.83M
수익:
-
순이익/손실:
$-15.52M
주가수익비율:
-0.0786
EPS:
-18.58
순현금흐름:
$-16.61M
1주 성능:
-0.68%
1개월 성능:
-59.44%
6개월 성능:
-84.92%
1년 성능:
-91.41%
1일 변동 폭
Value
$1.43
$1.57
1주일 범위
Value
$1.41
$1.6694
52주 변동 폭
Value
$1.41
$18.16

Revelation Biosciences Inc Stock (REVB) Company Profile

Name
명칭
Revelation Biosciences Inc
Name
전화
650-800-3717
Name
주소
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Name
직원
9
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
REVB's Discussions on Twitter

Compare REVB vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
REVB
Revelation Biosciences Inc
1.46 3.93M 0 -15.52M -16.61M -18.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.02 117.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.65 82.35B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
833.54 51.64B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.48 42.58B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.42 38.87B 4.98B 69.60M 525.67M 0.5198

Revelation Biosciences Inc 주식(REVB)의 최신 뉴스

pulisher
10:00 AM

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - Columbia Daily Tribune

10:00 AM
pulisher
03:12 AM

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Lubbock Avalanche-Journal

03:12 AM
pulisher
Feb 11, 2026

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - Peoria Journal Star

Feb 11, 2026
pulisher
Feb 05, 2026

Breakout Zone: What are the risks of holding Revelation Biosciences IncJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Revelation Biosciences (REVB) Price Target Increased by 300.00% to 86.70 - Nasdaq

Feb 04, 2026
pulisher
Feb 03, 2026

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Victorville Daily Press

Feb 03, 2026
pulisher
Feb 01, 2026

Fundamentals Check: What is Graf Global Corp Debt Equity Composite Unitss valuation compared to sectorJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Buyback Watch: Is ETHE trading at a discountJuly 2025 Market Mood & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 29, 2026

Can Revelation Biosciences Inc. expand into new marketsPortfolio Value Report & Daily Market Momentum Tracking - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Is Revelation Biosciences Inc. Equity Warrant backed by strong institutional buyingWeekly Market Summary & Weekly Return Optimization Alerts - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Revelation Biosciences Raises Capital via Warrant Inducement - TipRanks

Jan 29, 2026
pulisher
Jan 29, 2026

Revelation Biosciences Signs Multiple Material Agreements - TradingView

Jan 29, 2026
pulisher
Jan 28, 2026

REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year - Asianet Newsable

Jan 28, 2026
pulisher
Jan 28, 2026

Will PSIG stock benefit from M AWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

US Market Recap: Whats the beta of Revelation Biosciences Inc stock2025 Volume Leaders & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 27, 2026

How Do Investors Really Feel About Revelation Biosciences Inc? - Benzinga

Jan 27, 2026
pulisher
Jan 27, 2026

Revelation Biosciences to implement 1-for-4 reverse stock split By Investing.com - Investing.com Nigeria

Jan 27, 2026
pulisher
Jan 26, 2026

Revelation Biosciences to Implement 1-for-4 Reverse Stock Split - marketscreener.com

Jan 26, 2026
pulisher
Jan 26, 2026

Revelation Biosciences to implement 1-for-4 reverse stock split - Investing.com

Jan 26, 2026
pulisher
Jan 26, 2026

Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026 - The Olympian

Jan 26, 2026
pulisher
Jan 26, 2026

Revelation Biosciences to combine 4 shares into 1 for Nasdaq bid - Stock Titan

Jan 26, 2026

Revelation Biosciences Inc (REVB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
자본화:     |  볼륨(24시간):